Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob J Zulk

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Bacteriophage-mediated reduction of uropathogenic <i>E. coli</i> from the urogenital epitheliumBishnu Joshi, Jacob J Zulk, Camille Serchejian, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Type 2 diabetes mellitus exacerbates vaginal group B <i>Streptococcus</i> colonization via impaired mucosal cytokine responseClare M Robertson, Vicki Mercado-Evans, Addison B Larson, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
Distinct maternofetal immune signatures delineate preterm birth onset following urinary tract infectionSamantha Ottinger, Addison B Larson, Vicki Mercado-Evans, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Human bladder organoids model urinary tract infection and bacteriophage therapyJacob J Zulk, Clare M Robertson, Samantha Ottinger, et al.
Infection and Immunity|April 9, 2024
Progress toward a vaccine for extraintestinal pathogenic <i>E. coli</i> (ExPEC) II: efficacy of a toxin-autotransporter dual antigen approachYikun Xing, Justin R Clark, James D Chang, et al.
Infection and Immunity|February 26, 2026
Bacteriophage-mediated reduction of uropathogenic <i>E. coli</i> from the urogenital epitheliumBishnu Joshi, Jacob J Zulk, Camille Serchejian, et al.
Msphere|August 3, 2022
Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary EnvironmentJacob J Zulk, Justin R Clark, Samantha Ottinger, et al.
Msphere|July 10, 2026
Type 2 diabetes mellitus exacerbates vaginal group B <i>Streptococcus</i> colonization via impaired mucosal cytokine responseClare M Robertson, Vicki Mercado-Evans, Addison B Larson, et al.
Nature Communications|February 3, 2024
Gestational diabetes augments group B Streptococcus infection by disrupting maternal immunity and the vaginal microbiotaVicki Mercado-Evans, Marlyd E Mejia, Jacob J Zulk, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Bacteriophage-mediated reduction of uropathogenic <i>E. coli</i> from the urogenital epitheliumBishnu Joshi, Jacob J Zulk, Camille Serchejian, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Type 2 diabetes mellitus exacerbates vaginal group B <i>Streptococcus</i> colonization via impaired mucosal cytokine responseClare M Robertson, Vicki Mercado-Evans, Addison B Larson, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
Distinct maternofetal immune signatures delineate preterm birth onset following urinary tract infectionSamantha Ottinger, Addison B Larson, Vicki Mercado-Evans, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Human bladder organoids model urinary tract infection and bacteriophage therapyJacob J Zulk, Clare M Robertson, Samantha Ottinger, et al.
Infection and Immunity|April 9, 2024
Progress toward a vaccine for extraintestinal pathogenic <i>E. coli</i> (ExPEC) II: efficacy of a toxin-autotransporter dual antigen approachYikun Xing, Justin R Clark, James D Chang, et al.
Infection and Immunity|February 26, 2026
Bacteriophage-mediated reduction of uropathogenic <i>E. coli</i> from the urogenital epitheliumBishnu Joshi, Jacob J Zulk, Camille Serchejian, et al.
Msphere|August 3, 2022
Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary EnvironmentJacob J Zulk, Justin R Clark, Samantha Ottinger, et al.
Msphere|July 10, 2026
Type 2 diabetes mellitus exacerbates vaginal group B <i>Streptococcus</i> colonization via impaired mucosal cytokine responseClare M Robertson, Vicki Mercado-Evans, Addison B Larson, et al.
Nature Communications|February 3, 2024
Gestational diabetes augments group B Streptococcus infection by disrupting maternal immunity and the vaginal microbiotaVicki Mercado-Evans, Marlyd E Mejia, Jacob J Zulk, et al.
Pageof 2